nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—ABCB1—lung cancer	0.17	1	CbGaD
Levofloxacin—TOP2A—Teniposide—lung cancer	0.127	0.238	CbGbCtD
Levofloxacin—TOP2A—Etoposide—lung cancer	0.056	0.105	CbGbCtD
Levofloxacin—TOP2A—Doxorubicin—lung cancer	0.0382	0.0715	CbGbCtD
Levofloxacin—SLC22A2—Vinblastine—lung cancer	0.0312	0.0585	CbGbCtD
Levofloxacin—SLC22A2—Cisplatin—lung cancer	0.0287	0.0536	CbGbCtD
Levofloxacin—ABCB1—Topotecan—lung cancer	0.0192	0.0358	CbGbCtD
Levofloxacin—ABCB1—Gefitinib—lung cancer	0.0175	0.0328	CbGbCtD
Levofloxacin—ABCB1—Vinorelbine—lung cancer	0.0135	0.0253	CbGbCtD
Levofloxacin—CYP1A2—Erlotinib—lung cancer	0.0118	0.0222	CbGbCtD
Levofloxacin—CYP3A4—Topotecan—lung cancer	0.0115	0.0215	CbGbCtD
Levofloxacin—SLC22A6—Methotrexate—lung cancer	0.0111	0.0208	CbGbCtD
Levofloxacin—ABCB1—Crizotinib—lung cancer	0.0107	0.0201	CbGbCtD
Levofloxacin—CYP3A4—Gefitinib—lung cancer	0.0105	0.0196	CbGbCtD
Levofloxacin—ABCB1—Gemcitabine—lung cancer	0.0105	0.0196	CbGbCtD
Levofloxacin—ABCB1—Erlotinib—lung cancer	0.0104	0.0194	CbGbCtD
Levofloxacin—CYP3A4—Teniposide—lung cancer	0.0102	0.019	CbGbCtD
Levofloxacin—ABCB1—Paclitaxel—lung cancer	0.00948	0.0177	CbGbCtD
Levofloxacin—ABCB1—Irinotecan—lung cancer	0.00935	0.0175	CbGbCtD
Levofloxacin—CYP1A2—Etoposide—lung cancer	0.00857	0.016	CbGbCtD
Levofloxacin—ABCB1—Vinblastine—lung cancer	0.00832	0.0156	CbGbCtD
Levofloxacin—CYP3A4—Vinorelbine—lung cancer	0.00809	0.0151	CbGbCtD
Levofloxacin—ABCB1—Cisplatin—lung cancer	0.00763	0.0143	CbGbCtD
Levofloxacin—ABCB1—Etoposide—lung cancer	0.00749	0.014	CbGbCtD
Levofloxacin—ABCB1—Docetaxel—lung cancer	0.00686	0.0128	CbGbCtD
Levofloxacin—CYP3A4—Crizotinib—lung cancer	0.00643	0.012	CbGbCtD
Levofloxacin—CYP3A4—Erlotinib—lung cancer	0.00621	0.0116	CbGbCtD
Levofloxacin—CYP3A4—Paclitaxel—lung cancer	0.00568	0.0106	CbGbCtD
Levofloxacin—CYP3A4—Irinotecan—lung cancer	0.0056	0.0105	CbGbCtD
Levofloxacin—ABCB1—Doxorubicin—lung cancer	0.00511	0.00956	CbGbCtD
Levofloxacin—CYP3A4—Vinblastine—lung cancer	0.00498	0.00933	CbGbCtD
Levofloxacin—ABCB1—Methotrexate—lung cancer	0.00495	0.00927	CbGbCtD
Levofloxacin—CYP3A4—Etoposide—lung cancer	0.00449	0.0084	CbGbCtD
Levofloxacin—CYP3A4—Docetaxel—lung cancer	0.00411	0.00769	CbGbCtD
Levofloxacin—CYP3A4—Doxorubicin—lung cancer	0.00306	0.00573	CbGbCtD
Levofloxacin—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000437	0.097	CbGdCrCtD
Levofloxacin—Gatifloxacin—ALB—lung cancer	0.000411	0.273	CrCbGaD
Levofloxacin—Norfloxacin—CYP2A6—lung cancer	0.000392	0.26	CrCbGaD
Levofloxacin—TOP2A—Irinotecan—Topotecan—lung cancer	0.000374	0.0831	CbGdCrCtD
Levofloxacin—TOP2A—Erlotinib—Gefitinib—lung cancer	0.000326	0.0725	CbGdCrCtD
Levofloxacin—TOP2A—Topotecan—Irinotecan—lung cancer	0.000311	0.069	CbGdCrCtD
Levofloxacin—TOP2A—Etoposide—Teniposide—lung cancer	0.000309	0.0686	CbGdCrCtD
Levofloxacin—TOP2A—Vindesine—Vinorelbine—lung cancer	0.000278	0.0617	CbGdCrCtD
Levofloxacin—Norfloxacin—CYP1A1—lung cancer	0.000275	0.182	CrCbGaD
Levofloxacin—Sparfloxacin—ABCB1—lung cancer	0.000256	0.17	CrCbGaD
Levofloxacin—TOP2A—Podofilox—Teniposide—lung cancer	0.000235	0.0523	CbGdCrCtD
Levofloxacin—TOP2A—Vindesine—Vinblastine—lung cancer	0.000222	0.0493	CbGdCrCtD
Levofloxacin—TOP2A—Methotrexate—Pemetrexed—lung cancer	0.000222	0.0492	CbGdCrCtD
Levofloxacin—TOP2A—Paclitaxel—Docetaxel—lung cancer	0.000218	0.0484	CbGdCrCtD
Levofloxacin—TOP2A—Afatinib—Gefitinib—lung cancer	0.000213	0.0474	CbGdCrCtD
Levofloxacin—TOP2A—Gefitinib—Erlotinib—lung cancer	0.000209	0.0465	CbGdCrCtD
Levofloxacin—Ciprofloxacin—ABCB1—lung cancer	0.000174	0.115	CrCbGaD
Levofloxacin—TOP2A—Vincristine—Vinorelbine—lung cancer	0.00015	0.0333	CbGdCrCtD
Levofloxacin—TOP2A—Vinorelbine—Vinblastine—lung cancer	0.00014	0.0311	CbGdCrCtD
Levofloxacin—TOP2A—Teniposide—Etoposide—lung cancer	0.00014	0.0311	CbGdCrCtD
Levofloxacin—TOP2A—Podofilox—Etoposide—lung cancer	0.00014	0.0311	CbGdCrCtD
Levofloxacin—TOP2A—Vinblastine—Vinorelbine—lung cancer	0.000121	0.0268	CbGdCrCtD
Levofloxacin—TOP2A—Vincristine—Vinblastine—lung cancer	0.00012	0.0266	CbGdCrCtD
Levofloxacin—TOP2A—Cytarabine—Gemcitabine—lung cancer	7.87e-05	0.0175	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Doxorubicin—lung cancer	6.76e-05	0.015	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Doxorubicin—lung cancer	6.76e-05	0.015	CbGdCrCtD
Levofloxacin—TOP2A—Epirubicin—Doxorubicin—lung cancer	6.76e-05	0.015	CbGdCrCtD
Levofloxacin—TOP2A—Azacitidine—Gemcitabine—lung cancer	5.64e-05	0.0125	CbGdCrCtD
Levofloxacin—Infection—Docetaxel—lung cancer	3.82e-05	0.000176	CcSEcCtD
Levofloxacin—Weight decreased—Doxorubicin—lung cancer	3.82e-05	0.000176	CcSEcCtD
Levofloxacin—Feeling abnormal—Etoposide—lung cancer	3.81e-05	0.000175	CcSEcCtD
Levofloxacin—Hyperglycaemia—Doxorubicin—lung cancer	3.81e-05	0.000175	CcSEcCtD
Levofloxacin—Diarrhoea—Irinotecan—lung cancer	3.81e-05	0.000175	CcSEcCtD
Levofloxacin—Pneumonia—Doxorubicin—lung cancer	3.79e-05	0.000174	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Etoposide—lung cancer	3.78e-05	0.000174	CcSEcCtD
Levofloxacin—Shock—Docetaxel—lung cancer	3.78e-05	0.000174	CcSEcCtD
Levofloxacin—Nervous system disorder—Docetaxel—lung cancer	3.77e-05	0.000173	CcSEcCtD
Levofloxacin—Thrombocytopenia—Docetaxel—lung cancer	3.77e-05	0.000173	CcSEcCtD
Levofloxacin—Drowsiness—Doxorubicin—lung cancer	3.76e-05	0.000173	CcSEcCtD
Levofloxacin—Infestation—Doxorubicin—lung cancer	3.76e-05	0.000173	CcSEcCtD
Levofloxacin—Infestation NOS—Doxorubicin—lung cancer	3.76e-05	0.000173	CcSEcCtD
Levofloxacin—Visual impairment—Methotrexate—lung cancer	3.76e-05	0.000173	CcSEcCtD
Levofloxacin—Tachycardia—Docetaxel—lung cancer	3.75e-05	0.000173	CcSEcCtD
Levofloxacin—Feeling abnormal—Paclitaxel—lung cancer	3.74e-05	0.000172	CcSEcCtD
Levofloxacin—Skin disorder—Docetaxel—lung cancer	3.74e-05	0.000172	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.73e-05	0.000172	CcSEcCtD
Levofloxacin—Hypersensitivity—Cisplatin—lung cancer	3.72e-05	0.000171	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Paclitaxel—lung cancer	3.71e-05	0.000171	CcSEcCtD
Levofloxacin—Diarrhoea—Gemcitabine—lung cancer	3.71e-05	0.00017	CcSEcCtD
Levofloxacin—Renal failure—Doxorubicin—lung cancer	3.7e-05	0.00017	CcSEcCtD
Levofloxacin—Erythema multiforme—Methotrexate—lung cancer	3.69e-05	0.00017	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Doxorubicin—lung cancer	3.69e-05	0.00017	CcSEcCtD
Levofloxacin—Dizziness—Irinotecan—lung cancer	3.68e-05	0.000169	CcSEcCtD
Levofloxacin—Urticaria—Etoposide—lung cancer	3.68e-05	0.000169	CcSEcCtD
Levofloxacin—Stomatitis—Doxorubicin—lung cancer	3.67e-05	0.000169	CcSEcCtD
Levofloxacin—Jaundice—Doxorubicin—lung cancer	3.67e-05	0.000169	CcSEcCtD
Levofloxacin—Anorexia—Docetaxel—lung cancer	3.67e-05	0.000169	CcSEcCtD
Levofloxacin—Abdominal pain—Etoposide—lung cancer	3.66e-05	0.000168	CcSEcCtD
Levofloxacin—Body temperature increased—Etoposide—lung cancer	3.66e-05	0.000168	CcSEcCtD
Levofloxacin—Conjunctivitis—Doxorubicin—lung cancer	3.66e-05	0.000168	CcSEcCtD
Levofloxacin—Eye disorder—Methotrexate—lung cancer	3.65e-05	0.000168	CcSEcCtD
Levofloxacin—Tinnitus—Methotrexate—lung cancer	3.64e-05	0.000167	CcSEcCtD
Levofloxacin—Asthenia—Cisplatin—lung cancer	3.62e-05	0.000167	CcSEcCtD
Levofloxacin—Cardiac disorder—Methotrexate—lung cancer	3.62e-05	0.000166	CcSEcCtD
Levofloxacin—Urticaria—Paclitaxel—lung cancer	3.6e-05	0.000166	CcSEcCtD
Levofloxacin—Hypotension—Docetaxel—lung cancer	3.59e-05	0.000165	CcSEcCtD
Levofloxacin—Haematuria—Doxorubicin—lung cancer	3.59e-05	0.000165	CcSEcCtD
Levofloxacin—Body temperature increased—Paclitaxel—lung cancer	3.59e-05	0.000165	CcSEcCtD
Levofloxacin—Abdominal pain—Paclitaxel—lung cancer	3.59e-05	0.000165	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Doxorubicin—lung cancer	3.56e-05	0.000164	CcSEcCtD
Levofloxacin—Epistaxis—Doxorubicin—lung cancer	3.55e-05	0.000163	CcSEcCtD
Levofloxacin—Angiopathy—Methotrexate—lung cancer	3.54e-05	0.000163	CcSEcCtD
Levofloxacin—Vomiting—Irinotecan—lung cancer	3.54e-05	0.000163	CcSEcCtD
Levofloxacin—Sinusitis—Doxorubicin—lung cancer	3.53e-05	0.000162	CcSEcCtD
Levofloxacin—Immune system disorder—Methotrexate—lung cancer	3.52e-05	0.000162	CcSEcCtD
Levofloxacin—Mediastinal disorder—Methotrexate—lung cancer	3.52e-05	0.000162	CcSEcCtD
Levofloxacin—Agranulocytosis—Doxorubicin—lung cancer	3.51e-05	0.000161	CcSEcCtD
Levofloxacin—Rash—Irinotecan—lung cancer	3.51e-05	0.000161	CcSEcCtD
Levofloxacin—Dermatitis—Irinotecan—lung cancer	3.5e-05	0.000161	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Docetaxel—lung cancer	3.5e-05	0.000161	CcSEcCtD
Levofloxacin—Chills—Methotrexate—lung cancer	3.5e-05	0.000161	CcSEcCtD
Levofloxacin—Headache—Irinotecan—lung cancer	3.49e-05	0.00016	CcSEcCtD
Levofloxacin—Insomnia—Docetaxel—lung cancer	3.48e-05	0.00016	CcSEcCtD
Levofloxacin—Diarrhoea—Cisplatin—lung cancer	3.46e-05	0.000159	CcSEcCtD
Levofloxacin—Paraesthesia—Docetaxel—lung cancer	3.45e-05	0.000159	CcSEcCtD
Levofloxacin—Alopecia—Methotrexate—lung cancer	3.45e-05	0.000158	CcSEcCtD
Levofloxacin—Vomiting—Gemcitabine—lung cancer	3.45e-05	0.000158	CcSEcCtD
Levofloxacin—Bradycardia—Doxorubicin—lung cancer	3.44e-05	0.000158	CcSEcCtD
Levofloxacin—Dyspnoea—Docetaxel—lung cancer	3.43e-05	0.000158	CcSEcCtD
Levofloxacin—Somnolence—Docetaxel—lung cancer	3.42e-05	0.000157	CcSEcCtD
Levofloxacin—Mental disorder—Methotrexate—lung cancer	3.42e-05	0.000157	CcSEcCtD
Levofloxacin—Rash—Gemcitabine—lung cancer	3.42e-05	0.000157	CcSEcCtD
Levofloxacin—Dermatitis—Gemcitabine—lung cancer	3.41e-05	0.000157	CcSEcCtD
Levofloxacin—Hypersensitivity—Etoposide—lung cancer	3.41e-05	0.000157	CcSEcCtD
Levofloxacin—Erythema—Methotrexate—lung cancer	3.4e-05	0.000156	CcSEcCtD
Levofloxacin—Malnutrition—Methotrexate—lung cancer	3.4e-05	0.000156	CcSEcCtD
Levofloxacin—Haemoglobin—Doxorubicin—lung cancer	3.4e-05	0.000156	CcSEcCtD
Levofloxacin—Headache—Gemcitabine—lung cancer	3.4e-05	0.000156	CcSEcCtD
Levofloxacin—Rhinitis—Doxorubicin—lung cancer	3.39e-05	0.000156	CcSEcCtD
Levofloxacin—Dyspepsia—Docetaxel—lung cancer	3.39e-05	0.000156	CcSEcCtD
Levofloxacin—Haemorrhage—Doxorubicin—lung cancer	3.38e-05	0.000155	CcSEcCtD
Levofloxacin—Hepatitis—Doxorubicin—lung cancer	3.38e-05	0.000155	CcSEcCtD
Levofloxacin—Hypoaesthesia—Doxorubicin—lung cancer	3.36e-05	0.000155	CcSEcCtD
Levofloxacin—Pharyngitis—Doxorubicin—lung cancer	3.35e-05	0.000154	CcSEcCtD
Levofloxacin—Decreased appetite—Docetaxel—lung cancer	3.34e-05	0.000154	CcSEcCtD
Levofloxacin—Hypersensitivity—Paclitaxel—lung cancer	3.34e-05	0.000154	CcSEcCtD
Levofloxacin—Urinary tract disorder—Doxorubicin—lung cancer	3.34e-05	0.000153	CcSEcCtD
Levofloxacin—Oedema peripheral—Doxorubicin—lung cancer	3.33e-05	0.000153	CcSEcCtD
Levofloxacin—Dysgeusia—Methotrexate—lung cancer	3.33e-05	0.000153	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Docetaxel—lung cancer	3.32e-05	0.000153	CcSEcCtD
Levofloxacin—Asthenia—Etoposide—lung cancer	3.32e-05	0.000153	CcSEcCtD
Levofloxacin—Connective tissue disorder—Doxorubicin—lung cancer	3.32e-05	0.000153	CcSEcCtD
Levofloxacin—Fatigue—Docetaxel—lung cancer	3.32e-05	0.000152	CcSEcCtD
Levofloxacin—Urethral disorder—Doxorubicin—lung cancer	3.31e-05	0.000152	CcSEcCtD
Levofloxacin—Nausea—Irinotecan—lung cancer	3.3e-05	0.000152	CcSEcCtD
Levofloxacin—Pain—Docetaxel—lung cancer	3.29e-05	0.000151	CcSEcCtD
Levofloxacin—Constipation—Docetaxel—lung cancer	3.29e-05	0.000151	CcSEcCtD
Levofloxacin—Back pain—Methotrexate—lung cancer	3.29e-05	0.000151	CcSEcCtD
Levofloxacin—Pruritus—Etoposide—lung cancer	3.27e-05	0.000151	CcSEcCtD
Levofloxacin—Visual impairment—Doxorubicin—lung cancer	3.26e-05	0.00015	CcSEcCtD
Levofloxacin—Asthenia—Paclitaxel—lung cancer	3.26e-05	0.00015	CcSEcCtD
Levofloxacin—Nausea—Gemcitabine—lung cancer	3.22e-05	0.000148	CcSEcCtD
Levofloxacin—Vomiting—Cisplatin—lung cancer	3.21e-05	0.000148	CcSEcCtD
Levofloxacin—Pruritus—Paclitaxel—lung cancer	3.21e-05	0.000148	CcSEcCtD
Levofloxacin—Vision blurred—Methotrexate—lung cancer	3.2e-05	0.000147	CcSEcCtD
Levofloxacin—Erythema multiforme—Doxorubicin—lung cancer	3.19e-05	0.000147	CcSEcCtD
Levofloxacin—Rash—Cisplatin—lung cancer	3.19e-05	0.000146	CcSEcCtD
Levofloxacin—Dermatitis—Cisplatin—lung cancer	3.18e-05	0.000146	CcSEcCtD
Levofloxacin—Feeling abnormal—Docetaxel—lung cancer	3.17e-05	0.000146	CcSEcCtD
Levofloxacin—Diarrhoea—Etoposide—lung cancer	3.17e-05	0.000146	CcSEcCtD
Levofloxacin—Eye disorder—Doxorubicin—lung cancer	3.16e-05	0.000145	CcSEcCtD
Levofloxacin—Ill-defined disorder—Methotrexate—lung cancer	3.15e-05	0.000145	CcSEcCtD
Levofloxacin—Tinnitus—Doxorubicin—lung cancer	3.15e-05	0.000145	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Docetaxel—lung cancer	3.14e-05	0.000145	CcSEcCtD
Levofloxacin—Anaemia—Methotrexate—lung cancer	3.14e-05	0.000144	CcSEcCtD
Levofloxacin—Flushing—Doxorubicin—lung cancer	3.14e-05	0.000144	CcSEcCtD
Levofloxacin—Cardiac disorder—Doxorubicin—lung cancer	3.14e-05	0.000144	CcSEcCtD
Levofloxacin—Diarrhoea—Paclitaxel—lung cancer	3.1e-05	0.000143	CcSEcCtD
Levofloxacin—Angiopathy—Doxorubicin—lung cancer	3.07e-05	0.000141	CcSEcCtD
Levofloxacin—Malaise—Methotrexate—lung cancer	3.06e-05	0.000141	CcSEcCtD
Levofloxacin—Dizziness—Etoposide—lung cancer	3.06e-05	0.000141	CcSEcCtD
Levofloxacin—Immune system disorder—Doxorubicin—lung cancer	3.05e-05	0.00014	CcSEcCtD
Levofloxacin—Vertigo—Methotrexate—lung cancer	3.05e-05	0.00014	CcSEcCtD
Levofloxacin—Mediastinal disorder—Doxorubicin—lung cancer	3.04e-05	0.00014	CcSEcCtD
Levofloxacin—Body temperature increased—Docetaxel—lung cancer	3.04e-05	0.00014	CcSEcCtD
Levofloxacin—Abdominal pain—Docetaxel—lung cancer	3.04e-05	0.00014	CcSEcCtD
Levofloxacin—Leukopenia—Methotrexate—lung cancer	3.04e-05	0.00014	CcSEcCtD
Levofloxacin—Chills—Doxorubicin—lung cancer	3.03e-05	0.000139	CcSEcCtD
Levofloxacin—Arrhythmia—Doxorubicin—lung cancer	3.02e-05	0.000139	CcSEcCtD
Levofloxacin—Dizziness—Paclitaxel—lung cancer	3e-05	0.000138	CcSEcCtD
Levofloxacin—Nausea—Cisplatin—lung cancer	3e-05	0.000138	CcSEcCtD
Levofloxacin—Alopecia—Doxorubicin—lung cancer	2.99e-05	0.000137	CcSEcCtD
Levofloxacin—Cough—Methotrexate—lung cancer	2.96e-05	0.000136	CcSEcCtD
Levofloxacin—Mental disorder—Doxorubicin—lung cancer	2.96e-05	0.000136	CcSEcCtD
Levofloxacin—Vomiting—Etoposide—lung cancer	2.94e-05	0.000135	CcSEcCtD
Levofloxacin—Malnutrition—Doxorubicin—lung cancer	2.94e-05	0.000135	CcSEcCtD
Levofloxacin—Erythema—Doxorubicin—lung cancer	2.94e-05	0.000135	CcSEcCtD
Levofloxacin—Rash—Etoposide—lung cancer	2.92e-05	0.000134	CcSEcCtD
Levofloxacin—Dermatitis—Etoposide—lung cancer	2.92e-05	0.000134	CcSEcCtD
Levofloxacin—Headache—Etoposide—lung cancer	2.9e-05	0.000133	CcSEcCtD
Levofloxacin—Flatulence—Doxorubicin—lung cancer	2.9e-05	0.000133	CcSEcCtD
Levofloxacin—Myalgia—Methotrexate—lung cancer	2.89e-05	0.000133	CcSEcCtD
Levofloxacin—Arthralgia—Methotrexate—lung cancer	2.89e-05	0.000133	CcSEcCtD
Levofloxacin—Chest pain—Methotrexate—lung cancer	2.89e-05	0.000133	CcSEcCtD
Levofloxacin—Tension—Doxorubicin—lung cancer	2.89e-05	0.000133	CcSEcCtD
Levofloxacin—Vomiting—Paclitaxel—lung cancer	2.89e-05	0.000133	CcSEcCtD
Levofloxacin—Dysgeusia—Doxorubicin—lung cancer	2.88e-05	0.000132	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.87e-05	0.000132	CcSEcCtD
Levofloxacin—Rash—Paclitaxel—lung cancer	2.86e-05	0.000132	CcSEcCtD
Levofloxacin—Dermatitis—Paclitaxel—lung cancer	2.86e-05	0.000131	CcSEcCtD
Levofloxacin—Discomfort—Methotrexate—lung cancer	2.86e-05	0.000131	CcSEcCtD
Levofloxacin—Nervousness—Doxorubicin—lung cancer	2.86e-05	0.000131	CcSEcCtD
Levofloxacin—Back pain—Doxorubicin—lung cancer	2.84e-05	0.000131	CcSEcCtD
Levofloxacin—Headache—Paclitaxel—lung cancer	2.84e-05	0.000131	CcSEcCtD
Levofloxacin—Hypersensitivity—Docetaxel—lung cancer	2.83e-05	0.00013	CcSEcCtD
Levofloxacin—Muscle spasms—Doxorubicin—lung cancer	2.83e-05	0.00013	CcSEcCtD
Levofloxacin—Confusional state—Methotrexate—lung cancer	2.8e-05	0.000128	CcSEcCtD
Levofloxacin—Anaphylactic shock—Methotrexate—lung cancer	2.77e-05	0.000127	CcSEcCtD
Levofloxacin—Vision blurred—Doxorubicin—lung cancer	2.77e-05	0.000127	CcSEcCtD
Levofloxacin—Asthenia—Docetaxel—lung cancer	2.76e-05	0.000127	CcSEcCtD
Levofloxacin—Infection—Methotrexate—lung cancer	2.75e-05	0.000127	CcSEcCtD
Levofloxacin—Nausea—Etoposide—lung cancer	2.75e-05	0.000126	CcSEcCtD
Levofloxacin—Ill-defined disorder—Doxorubicin—lung cancer	2.73e-05	0.000125	CcSEcCtD
Levofloxacin—Pruritus—Docetaxel—lung cancer	2.72e-05	0.000125	CcSEcCtD
Levofloxacin—Nervous system disorder—Methotrexate—lung cancer	2.72e-05	0.000125	CcSEcCtD
Levofloxacin—Anaemia—Doxorubicin—lung cancer	2.72e-05	0.000125	CcSEcCtD
Levofloxacin—Thrombocytopenia—Methotrexate—lung cancer	2.71e-05	0.000125	CcSEcCtD
Levofloxacin—Agitation—Doxorubicin—lung cancer	2.7e-05	0.000124	CcSEcCtD
Levofloxacin—Nausea—Paclitaxel—lung cancer	2.7e-05	0.000124	CcSEcCtD
Levofloxacin—Skin disorder—Methotrexate—lung cancer	2.69e-05	0.000124	CcSEcCtD
Levofloxacin—Hyperhidrosis—Methotrexate—lung cancer	2.68e-05	0.000123	CcSEcCtD
Levofloxacin—Malaise—Doxorubicin—lung cancer	2.65e-05	0.000122	CcSEcCtD
Levofloxacin—Vertigo—Doxorubicin—lung cancer	2.64e-05	0.000121	CcSEcCtD
Levofloxacin—Anorexia—Methotrexate—lung cancer	2.64e-05	0.000121	CcSEcCtD
Levofloxacin—Syncope—Doxorubicin—lung cancer	2.64e-05	0.000121	CcSEcCtD
Levofloxacin—Leukopenia—Doxorubicin—lung cancer	2.63e-05	0.000121	CcSEcCtD
Levofloxacin—Diarrhoea—Docetaxel—lung cancer	2.63e-05	0.000121	CcSEcCtD
Levofloxacin—Palpitations—Doxorubicin—lung cancer	2.6e-05	0.000119	CcSEcCtD
Levofloxacin—Hypotension—Methotrexate—lung cancer	2.59e-05	0.000119	CcSEcCtD
Levofloxacin—Loss of consciousness—Doxorubicin—lung cancer	2.58e-05	0.000119	CcSEcCtD
Levofloxacin—Cough—Doxorubicin—lung cancer	2.57e-05	0.000118	CcSEcCtD
Levofloxacin—Dizziness—Docetaxel—lung cancer	2.54e-05	0.000117	CcSEcCtD
Levofloxacin—Hypertension—Doxorubicin—lung cancer	2.54e-05	0.000117	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Methotrexate—lung cancer	2.53e-05	0.000116	CcSEcCtD
Levofloxacin—Insomnia—Methotrexate—lung cancer	2.51e-05	0.000115	CcSEcCtD
Levofloxacin—Arthralgia—Doxorubicin—lung cancer	2.5e-05	0.000115	CcSEcCtD
Levofloxacin—Myalgia—Doxorubicin—lung cancer	2.5e-05	0.000115	CcSEcCtD
Levofloxacin—Chest pain—Doxorubicin—lung cancer	2.5e-05	0.000115	CcSEcCtD
Levofloxacin—Anxiety—Doxorubicin—lung cancer	2.5e-05	0.000115	CcSEcCtD
Levofloxacin—Paraesthesia—Methotrexate—lung cancer	2.49e-05	0.000114	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.49e-05	0.000114	CcSEcCtD
Levofloxacin—Discomfort—Doxorubicin—lung cancer	2.47e-05	0.000114	CcSEcCtD
Levofloxacin—Dyspnoea—Methotrexate—lung cancer	2.47e-05	0.000114	CcSEcCtD
Levofloxacin—Somnolence—Methotrexate—lung cancer	2.46e-05	0.000113	CcSEcCtD
Levofloxacin—Dry mouth—Doxorubicin—lung cancer	2.45e-05	0.000113	CcSEcCtD
Levofloxacin—Vomiting—Docetaxel—lung cancer	2.45e-05	0.000112	CcSEcCtD
Levofloxacin—Dyspepsia—Methotrexate—lung cancer	2.44e-05	0.000112	CcSEcCtD
Levofloxacin—Rash—Docetaxel—lung cancer	2.42e-05	0.000111	CcSEcCtD
Levofloxacin—Dermatitis—Docetaxel—lung cancer	2.42e-05	0.000111	CcSEcCtD
Levofloxacin—Confusional state—Doxorubicin—lung cancer	2.42e-05	0.000111	CcSEcCtD
Levofloxacin—Decreased appetite—Methotrexate—lung cancer	2.41e-05	0.000111	CcSEcCtD
Levofloxacin—Headache—Docetaxel—lung cancer	2.41e-05	0.000111	CcSEcCtD
Levofloxacin—Anaphylactic shock—Doxorubicin—lung cancer	2.4e-05	0.00011	CcSEcCtD
Levofloxacin—Oedema—Doxorubicin—lung cancer	2.4e-05	0.00011	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Methotrexate—lung cancer	2.39e-05	0.00011	CcSEcCtD
Levofloxacin—Fatigue—Methotrexate—lung cancer	2.39e-05	0.00011	CcSEcCtD
Levofloxacin—Infection—Doxorubicin—lung cancer	2.38e-05	0.00011	CcSEcCtD
Levofloxacin—Pain—Methotrexate—lung cancer	2.37e-05	0.000109	CcSEcCtD
Levofloxacin—Shock—Doxorubicin—lung cancer	2.36e-05	0.000109	CcSEcCtD
Levofloxacin—Nervous system disorder—Doxorubicin—lung cancer	2.35e-05	0.000108	CcSEcCtD
Levofloxacin—Thrombocytopenia—Doxorubicin—lung cancer	2.35e-05	0.000108	CcSEcCtD
Levofloxacin—Tachycardia—Doxorubicin—lung cancer	2.34e-05	0.000108	CcSEcCtD
Levofloxacin—Skin disorder—Doxorubicin—lung cancer	2.33e-05	0.000107	CcSEcCtD
Levofloxacin—Hyperhidrosis—Doxorubicin—lung cancer	2.32e-05	0.000107	CcSEcCtD
Levofloxacin—Anorexia—Doxorubicin—lung cancer	2.29e-05	0.000105	CcSEcCtD
Levofloxacin—Nausea—Docetaxel—lung cancer	2.28e-05	0.000105	CcSEcCtD
Levofloxacin—Feeling abnormal—Methotrexate—lung cancer	2.28e-05	0.000105	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Methotrexate—lung cancer	2.27e-05	0.000104	CcSEcCtD
Levofloxacin—Hypotension—Doxorubicin—lung cancer	2.24e-05	0.000103	CcSEcCtD
Levofloxacin—Urticaria—Methotrexate—lung cancer	2.2e-05	0.000101	CcSEcCtD
Levofloxacin—Body temperature increased—Methotrexate—lung cancer	2.19e-05	0.000101	CcSEcCtD
Levofloxacin—Abdominal pain—Methotrexate—lung cancer	2.19e-05	0.000101	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.19e-05	0.000101	CcSEcCtD
Levofloxacin—Insomnia—Doxorubicin—lung cancer	2.17e-05	9.98e-05	CcSEcCtD
Levofloxacin—Paraesthesia—Doxorubicin—lung cancer	2.16e-05	9.91e-05	CcSEcCtD
Levofloxacin—Dyspnoea—Doxorubicin—lung cancer	2.14e-05	9.84e-05	CcSEcCtD
Levofloxacin—Somnolence—Doxorubicin—lung cancer	2.13e-05	9.81e-05	CcSEcCtD
Levofloxacin—Dyspepsia—Doxorubicin—lung cancer	2.11e-05	9.71e-05	CcSEcCtD
Levofloxacin—Decreased appetite—Doxorubicin—lung cancer	2.09e-05	9.59e-05	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Doxorubicin—lung cancer	2.07e-05	9.53e-05	CcSEcCtD
Levofloxacin—Fatigue—Doxorubicin—lung cancer	2.07e-05	9.51e-05	CcSEcCtD
Levofloxacin—Pain—Doxorubicin—lung cancer	2.05e-05	9.44e-05	CcSEcCtD
Levofloxacin—Constipation—Doxorubicin—lung cancer	2.05e-05	9.44e-05	CcSEcCtD
Levofloxacin—Hypersensitivity—Methotrexate—lung cancer	2.04e-05	9.39e-05	CcSEcCtD
Levofloxacin—Asthenia—Methotrexate—lung cancer	1.99e-05	9.14e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Doxorubicin—lung cancer	1.98e-05	9.09e-05	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Doxorubicin—lung cancer	1.96e-05	9.02e-05	CcSEcCtD
Levofloxacin—Pruritus—Methotrexate—lung cancer	1.96e-05	9.02e-05	CcSEcCtD
Levofloxacin—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.93e-05	0.000268	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—HSD17B10—lung cancer	1.91e-05	0.000265	CbGpPWpGaD
Levofloxacin—Urticaria—Doxorubicin—lung cancer	1.91e-05	8.77e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.91e-05	0.000264	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GNG11—lung cancer	1.9e-05	0.000263	CbGpPWpGaD
Levofloxacin—Body temperature increased—Doxorubicin—lung cancer	1.9e-05	8.72e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Doxorubicin—lung cancer	1.9e-05	8.72e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Methotrexate—lung cancer	1.9e-05	8.72e-05	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	1.88e-05	0.00026	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—EP300—lung cancer	1.88e-05	0.00026	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ATP5H—lung cancer	1.87e-05	0.00026	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—POMC—lung cancer	1.87e-05	0.000259	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	1.85e-05	0.000257	CbGpPWpGaD
Levofloxacin—Dizziness—Methotrexate—lung cancer	1.83e-05	8.43e-05	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	1.83e-05	0.000253	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	1.83e-05	0.000253	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALDOA—lung cancer	1.81e-05	0.000251	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—APOA1—lung cancer	1.8e-05	0.000249	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.78e-05	0.000247	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CKB—lung cancer	1.78e-05	0.000246	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.77e-05	0.000246	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Doxorubicin—lung cancer	1.77e-05	8.13e-05	CcSEcCtD
Levofloxacin—Vomiting—Methotrexate—lung cancer	1.76e-05	8.1e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—NCOA3—lung cancer	1.76e-05	0.000244	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.75e-05	0.000243	CbGpPWpGaD
Levofloxacin—Rash—Methotrexate—lung cancer	1.75e-05	8.03e-05	CcSEcCtD
Levofloxacin—Dermatitis—Methotrexate—lung cancer	1.75e-05	8.03e-05	CcSEcCtD
Levofloxacin—Headache—Methotrexate—lung cancer	1.74e-05	7.98e-05	CcSEcCtD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—HRAS—lung cancer	1.72e-05	0.000239	CbGpPWpGaD
Levofloxacin—Asthenia—Doxorubicin—lung cancer	1.72e-05	7.92e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	1.72e-05	0.000239	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.72e-05	0.000238	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ADCY1—lung cancer	1.71e-05	0.000237	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCG2—lung cancer	1.71e-05	0.000237	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	1.71e-05	0.000237	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.7e-05	0.000236	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AZIN2—lung cancer	1.7e-05	0.000236	CbGpPWpGaD
Levofloxacin—Pruritus—Doxorubicin—lung cancer	1.7e-05	7.81e-05	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—MAPK3—lung cancer	1.68e-05	0.000233	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ENO2—lung cancer	1.68e-05	0.000232	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—HPGDS—lung cancer	1.68e-05	0.000232	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CNDP2—lung cancer	1.67e-05	0.000232	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTM2—lung cancer	1.67e-05	0.000232	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PLBD1—lung cancer	1.67e-05	0.000231	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PPP2R1B—lung cancer	1.67e-05	0.000231	CbGpPWpGaD
Levofloxacin—Nausea—Methotrexate—lung cancer	1.65e-05	7.57e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Doxorubicin—lung cancer	1.64e-05	7.55e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	1.64e-05	0.000228	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MYC—lung cancer	1.63e-05	0.000226	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—MTMR3—lung cancer	1.63e-05	0.000225	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTT1—lung cancer	1.63e-05	0.000225	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GCLC—lung cancer	1.61e-05	0.000223	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP2A6—lung cancer	1.61e-05	0.000223	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.59e-05	0.000221	CbGpPWpGaD
Levofloxacin—Dizziness—Doxorubicin—lung cancer	1.59e-05	7.3e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—PGAM1—lung cancer	1.58e-05	0.00022	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.55e-05	0.000215	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.55e-05	0.000214	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	1.55e-05	0.000214	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—HSD17B10—lung cancer	1.53e-05	0.000212	CbGpPWpGaD
Levofloxacin—Vomiting—Doxorubicin—lung cancer	1.53e-05	7.02e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—ENO1—lung cancer	1.52e-05	0.000211	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—CREBBP—lung cancer	1.52e-05	0.000211	CbGpPWpGaD
Levofloxacin—Rash—Doxorubicin—lung cancer	1.51e-05	6.96e-05	CcSEcCtD
Levofloxacin—Dermatitis—Doxorubicin—lung cancer	1.51e-05	6.95e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—CYP2A7—lung cancer	1.51e-05	0.00021	CbGpPWpGaD
Levofloxacin—Headache—Doxorubicin—lung cancer	1.5e-05	6.91e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.5e-05	0.000208	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.5e-05	0.000207	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SDC4—lung cancer	1.48e-05	0.000205	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ATP5H—lung cancer	1.45e-05	0.0002	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—POMC—lung cancer	1.44e-05	0.0002	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.43e-05	0.000198	CbGpPWpGaD
Levofloxacin—Nausea—Doxorubicin—lung cancer	1.43e-05	6.55e-05	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ALB—lung cancer	1.42e-05	0.000197	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CKB—lung cancer	1.42e-05	0.000197	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.39e-05	0.000192	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP2E1—lung cancer	1.37e-05	0.000189	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NQO1—lung cancer	1.35e-05	0.000187	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.35e-05	0.000187	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—RRM1—lung cancer	1.35e-05	0.000187	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTA3—lung cancer	1.35e-05	0.000187	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—lung cancer	1.34e-05	0.000186	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CNDP2—lung cancer	1.33e-05	0.000185	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTM2—lung cancer	1.33e-05	0.000185	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—HRAS—lung cancer	1.32e-05	0.000183	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—MTMR3—lung cancer	1.3e-05	0.00018	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—RAF1—lung cancer	1.29e-05	0.000179	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PLBD1—lung cancer	1.29e-05	0.000179	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.28e-05	0.000178	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.28e-05	0.000177	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—B4GALT5—lung cancer	1.27e-05	0.000176	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PGAM1—lung cancer	1.26e-05	0.000175	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.24e-05	0.000172	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTA4—lung cancer	1.23e-05	0.000171	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—STK11—lung cancer	1.22e-05	0.000169	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.22e-05	0.000169	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP2A7—lung cancer	1.21e-05	0.000167	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTA2—lung cancer	1.2e-05	0.000166	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SDC4—lung cancer	1.18e-05	0.000164	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—HSD17B10—lung cancer	1.18e-05	0.000163	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTA1—lung cancer	1.16e-05	0.000161	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.15e-05	0.000159	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ABCC3—lung cancer	1.15e-05	0.000159	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTP1—lung cancer	1.13e-05	0.000156	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AKR1C1—lung cancer	1.11e-05	0.000154	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CAT—lung cancer	1.1e-05	0.000152	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CKB—lung cancer	1.1e-05	0.000152	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—UGT1A1—lung cancer	1.08e-05	0.000149	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—RRM1—lung cancer	1.08e-05	0.000149	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTA3—lung cancer	1.08e-05	0.000149	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCB1—lung cancer	1.07e-05	0.000148	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.06e-05	0.000146	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TYMS—lung cancer	1.05e-05	0.000145	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GNG11—lung cancer	1.04e-05	0.000144	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTM1—lung cancer	1.04e-05	0.000144	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CNDP2—lung cancer	1.03e-05	0.000143	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTM2—lung cancer	1.03e-05	0.000143	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.02e-05	0.000141	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—B4GALT5—lung cancer	1.01e-05	0.00014	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—MTMR3—lung cancer	1e-05	0.000139	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALDOA—lung cancer	9.89e-06	0.000137	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTA4—lung cancer	9.84e-06	0.000136	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	9.82e-06	0.000136	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP1A1—lung cancer	9.82e-06	0.000136	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PGAM1—lung cancer	9.76e-06	0.000135	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ERCC2—lung cancer	9.74e-06	0.000135	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	9.61e-06	0.000133	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NCOA3—lung cancer	9.6e-06	0.000133	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTA2—lung cancer	9.59e-06	0.000133	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADCY1—lung cancer	9.34e-06	0.000129	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ABCG2—lung cancer	9.34e-06	0.000129	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP2A7—lung cancer	9.31e-06	0.000129	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTA1—lung cancer	9.25e-06	0.000128	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—HPGDS—lung cancer	9.16e-06	0.000127	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ENO2—lung cancer	9.16e-06	0.000127	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCC3—lung cancer	9.14e-06	0.000127	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SDC4—lung cancer	9.11e-06	0.000126	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PPP2R1B—lung cancer	9.1e-06	0.000126	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTT1—lung cancer	8.88e-06	0.000123	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AKR1C1—lung cancer	8.86e-06	0.000123	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP2A6—lung cancer	8.78e-06	0.000122	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GCLC—lung cancer	8.78e-06	0.000122	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.62e-06	0.000119	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—UGT1A1—lung cancer	8.6e-06	0.000119	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—APOA1—lung cancer	8.42e-06	0.000117	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ENO1—lung cancer	8.32e-06	0.000115	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	8.32e-06	0.000115	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—RRM1—lung cancer	8.3e-06	0.000115	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTA3—lung cancer	8.3e-06	0.000115	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GNG11—lung cancer	8.29e-06	0.000115	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8.25e-06	0.000114	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALDOA—lung cancer	7.89e-06	0.000109	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—B4GALT5—lung cancer	7.8e-06	0.000108	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	7.78e-06	0.000108	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CG—lung cancer	7.69e-06	0.000107	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NCOA3—lung cancer	7.66e-06	0.000106	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTA4—lung cancer	7.59e-06	0.000105	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.53e-06	0.000104	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP2E1—lung cancer	7.47e-06	0.000103	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADCY1—lung cancer	7.45e-06	0.000103	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCG2—lung cancer	7.45e-06	0.000103	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTA2—lung cancer	7.4e-06	0.000103	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NQO1—lung cancer	7.38e-06	0.000102	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—POMC—lung cancer	7.32e-06	0.000101	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—HPGDS—lung cancer	7.31e-06	0.000101	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ENO2—lung cancer	7.31e-06	0.000101	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PPP2R1B—lung cancer	7.26e-06	0.000101	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.17e-06	9.94e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTA1—lung cancer	7.14e-06	9.89e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CREBBP—lung cancer	7.13e-06	9.88e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTT1—lung cancer	7.09e-06	9.83e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCC3—lung cancer	7.06e-06	9.78e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	7.04e-06	9.76e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP2A6—lung cancer	7.01e-06	9.71e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GCLC—lung cancer	7.01e-06	9.71e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.98e-06	9.68e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AKR1C1—lung cancer	6.84e-06	9.47e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CD—lung cancer	6.76e-06	9.37e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALB—lung cancer	6.67e-06	9.25e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—STK11—lung cancer	6.65e-06	9.22e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ENO1—lung cancer	6.64e-06	9.21e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—UGT1A1—lung cancer	6.64e-06	9.2e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.62e-06	9.18e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.54e-06	9.06e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GNG11—lung cancer	6.4e-06	8.87e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTP1—lung cancer	6.16e-06	8.53e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALDOA—lung cancer	6.09e-06	8.44e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CAT—lung cancer	5.99e-06	8.3e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP2E1—lung cancer	5.96e-06	8.26e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NCOA3—lung cancer	5.91e-06	8.2e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NQO1—lung cancer	5.89e-06	8.17e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CB—lung cancer	5.89e-06	8.17e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS2—lung cancer	5.84e-06	8.09e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.77e-06	8e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADCY1—lung cancer	5.75e-06	7.97e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCG2—lung cancer	5.75e-06	7.97e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TYMS—lung cancer	5.72e-06	7.93e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.72e-06	7.92e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTM1—lung cancer	5.66e-06	7.84e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ENO2—lung cancer	5.64e-06	7.82e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—HPGDS—lung cancer	5.64e-06	7.82e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.61e-06	7.77e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTT1—lung cancer	5.47e-06	7.58e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GCLC—lung cancer	5.41e-06	7.5e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP2A6—lung cancer	5.41e-06	7.5e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP1A1—lung cancer	5.36e-06	7.43e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ERCC2—lung cancer	5.32e-06	7.37e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—STK11—lung cancer	5.31e-06	7.36e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ENO1—lung cancer	5.13e-06	7.11e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTEN—lung cancer	5.09e-06	7.06e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.99e-06	6.91e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTP1—lung cancer	4.91e-06	6.81e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—EP300—lung cancer	4.86e-06	6.73e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CAT—lung cancer	4.78e-06	6.63e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.76e-06	6.59e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCB1—lung cancer	4.65e-06	6.45e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—APOA1—lung cancer	4.6e-06	6.38e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP2E1—lung cancer	4.6e-06	6.37e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TYMS—lung cancer	4.57e-06	6.33e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NQO1—lung cancer	4.55e-06	6.3e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTM1—lung cancer	4.52e-06	6.26e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP1A1—lung cancer	4.28e-06	5.93e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ERCC2—lung cancer	4.25e-06	5.89e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CG—lung cancer	4.2e-06	5.82e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—STK11—lung cancer	4.1e-06	5.68e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—POMC—lung cancer	4e-06	5.54e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CREBBP—lung cancer	3.9e-06	5.4e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTP1—lung cancer	3.79e-06	5.26e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CD—lung cancer	3.69e-06	5.12e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CAT—lung cancer	3.69e-06	5.12e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—APOA1—lung cancer	3.67e-06	5.09e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALB—lung cancer	3.65e-06	5.05e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CA—lung cancer	3.59e-06	4.98e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCB1—lung cancer	3.59e-06	4.98e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TYMS—lung cancer	3.53e-06	4.89e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.52e-06	4.88e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTM1—lung cancer	3.49e-06	4.83e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CG—lung cancer	3.35e-06	4.65e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP1A1—lung cancer	3.3e-06	4.58e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ERCC2—lung cancer	3.28e-06	4.54e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CB—lung cancer	3.22e-06	4.46e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—POMC—lung cancer	3.19e-06	4.42e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS2—lung cancer	3.19e-06	4.42e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CREBBP—lung cancer	3.11e-06	4.31e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CD—lung cancer	2.95e-06	4.09e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AKT1—lung cancer	2.93e-06	4.07e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALB—lung cancer	2.91e-06	4.03e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—APOA1—lung cancer	2.84e-06	3.93e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTEN—lung cancer	2.78e-06	3.86e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—EP300—lung cancer	2.65e-06	3.68e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CG—lung cancer	2.59e-06	3.59e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CB—lung cancer	2.57e-06	3.56e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS2—lung cancer	2.55e-06	3.53e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—POMC—lung cancer	2.46e-06	3.41e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CREBBP—lung cancer	2.4e-06	3.33e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CD—lung cancer	2.28e-06	3.15e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALB—lung cancer	2.25e-06	3.11e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTEN—lung cancer	2.22e-06	3.08e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—EP300—lung cancer	2.12e-06	2.94e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CB—lung cancer	1.98e-06	2.75e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS2—lung cancer	1.97e-06	2.72e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CA—lung cancer	1.96e-06	2.72e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTEN—lung cancer	1.71e-06	2.38e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—EP300—lung cancer	1.63e-06	2.27e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AKT1—lung cancer	1.6e-06	2.22e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CA—lung cancer	1.57e-06	2.17e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AKT1—lung cancer	1.28e-06	1.77e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CA—lung cancer	1.21e-06	1.68e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AKT1—lung cancer	9.88e-07	1.37e-05	CbGpPWpGaD
